Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hilton Lac-Leamy

Oct 27, 2025 7:30 AM - Oct 28, 2025 3:40 PM

3 Boulevard du Casino, Gatineau, QC J8Y 6X4, Canada

Canada Annual Meeting

The Canada Annual Meeting offers three tracks, Regulatory, Clinical, Safety and Pharmacovigilance!

Session 5, Track B: Navigating the Quality by Design and Inspection Process for Enhanced Safety and Result Reliability of Clinical Trials

Session Chair(s)

Katalin  Bertenyi, MSc

Katalin Bertenyi, MSc

Manager, Centre for Blood, Blood Products and Biotherapeutics

Health Canada, Canada

Hocine  Abid, MD, MBA

Hocine Abid, MD, MBA

National Manager, Regulatory Operations and Enforcement Branch

Health Canada, Canada

This session is geared toward clinical trial sponsors, investigators, and study coordinators to promote Good Clinical Practices (GCP) as per the new ICH E6 R3. Speakers will provide helpful guidance on ensuring compliance with the regulatory requirements to initiate a clinical trial in Canada. The session will conclude with a Q&A period which will give participants the opportunity to ask the Health Canada representative for additional clarification.

  • Navigating Good Clinical Practice Inspections with Health Canada
    Kevin Donato, Health Canada
  • ICH E6(R3) Foundational Concepts and Overview of Selected Highlights
    Katherine Soltys, Health Canada
  • Good Clinical Practices in the Context of the Clinical Trial Application Process
    Sophie Hamel, Health Canada
  • Navigating Good Clinical Practice Inspections with Health Canada: Clinical Trial Compliance Program Overview
    Alex Basiji, Health Canada

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify the key changes with ICH E6(R3), and how this will impact Health Canada and Canadians
  • How to prepare a successful clinical trial application
  • How to prepare for a successful regulatory GCP inspection under the GCP standard (ICH E6R3)
  • Understand the key elements for a proportionate risk-based approach to inspection

Speaker(s)

Sophie  Hamel, PhD, MSc

Good Clinical Practices in the Context of the Clinical Trial Application Process

Sophie Hamel, PhD, MSc

Health Canada, Canada

Senior Clinical Reviewer, PDD OCT

Katherine M. Soltys, MD

ICH E6(R3) Foundational Concepts and Overview of Selected Highlights

Katherine M. Soltys, MD

Health Canada, Canada

Director, Office of Clinical Trials, Pharmaceutical Drug Directorate

Alex  Basiji

Navigating Good Clinical Practice Inspections with Health Canada: Clinical Trial Compliance Program Overview

Alex Basiji

Health Canada, Canada

National Director of Clinical Compliance and Border Operations

Kevin  Donato, PhD

Navigating Good Clinical Practice Inspections with Health Canada

Kevin Donato, PhD

Health Canada, Canada

Senior Compliance & Enforcement Advisor

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.